174 related articles for article (PubMed ID: 29379494)
1. The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide.
Shaim H; Estrov Z; Harris D; Hernandez Sanabria M; Liu Z; Ruvolo P; Thompson PA; Ferrajoli A; Daher M; Burger J; Muftuoglu M; Imahashi N; Li L; Liu E; Alsuliman AS; Basar R; Nassif Kerbauy L; Sobieski C; Gokdemir E; Kondo K; Wierda W; Keating M; Shpall EJ; Rezvani K
Front Immunol; 2017; 8():1773. PubMed ID: 29379494
[TBL] [Abstract][Full Text] [Related]
2. The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6.
Lu K; Fang XS; Feng LL; Jiang YJ; Zhou XX; Liu X; Li PP; Chen N; Ding M; Wang N; Zhang J; Wang X
Cancer Lett; 2015 Apr; 359(2):250-8. PubMed ID: 25636517
[TBL] [Abstract][Full Text] [Related]
3. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
[TBL] [Abstract][Full Text] [Related]
4. CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease.
Barretina J; Juncà J; Llano A; Gutiérrez A; Flores A; Blanco J; Clotet B; Esté JA
Ann Hematol; 2003 Aug; 82(8):500-505. PubMed ID: 12783211
[TBL] [Abstract][Full Text] [Related]
5. STAT3 mediates C6-ceramide-induced cell death in chronic lymphocytic leukemia.
Doshi UA; Shaw J; Fox TE; Claxton DF; Loughran TP; Kester M
Signal Transduct Target Ther; 2017; 2():17051. PubMed ID: 29263930
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of IL-9 induced by STAT3 phosphorylation is mediated by miR-155 and miR-21 in chronic lymphocytic leukemia.
Chen N; Feng L; Qu H; Lu K; Li P; Lv X; Wang X
Oncol Rep; 2018 Jun; 39(6):3064-3072. PubMed ID: 29658610
[TBL] [Abstract][Full Text] [Related]
7. JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia.
Montresor A; Toffali L; Mirenda M; Rigo A; Vinante F; Laudanna C
Oncotarget; 2015 Oct; 6(33):34245-57. PubMed ID: 26413812
[TBL] [Abstract][Full Text] [Related]
8. Lenalidomide in the treatment of chronic lymphocytic leukemia.
Itchaki G; Brown JR
Expert Opin Investig Drugs; 2017 May; 26(5):633-650. PubMed ID: 28388253
[TBL] [Abstract][Full Text] [Related]
9. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
[TBL] [Abstract][Full Text] [Related]
10. CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation.
Garaud S; Morva A; Lemoine S; Hillion S; Bordron A; Pers JO; Berthou C; Mageed RA; Renaudineau Y; Youinou P
J Immunol; 2011 Apr; 186(8):4835-44. PubMed ID: 21398617
[TBL] [Abstract][Full Text] [Related]
11. IL-6, IL-10, c-Jun and STAT3 expression in B-CLL.
Antosz H; Wojciechowska K; Sajewicz J; Choroszyńska D; Marzec-Kotarska B; Osiak M; Pająk N; Tomczak W; Jargiełło-Baszak M; Baszak J
Blood Cells Mol Dis; 2015 Mar; 54(3):258-65. PubMed ID: 25477266
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes.
Sherry B; Jain P; Chiu PY; Leung L; Allen SL; Kolitz JE; Rai KR; Barrientos J; Liang S; Hawtin R; Chiorazzi N
Immunol Res; 2015 Dec; 63(1-3):216-27. PubMed ID: 26478573
[TBL] [Abstract][Full Text] [Related]
13. Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia.
Maffei R; Fiorcari S; Bulgarelli J; Rizzotto L; Martinelli S; Rigolin GM; Debbia G; Castelli I; Bonacorsi G; Santachiara R; Forconi F; Rossi D; Laurenti L; Palumbo GA; Vallisa D; Cuneo A; Gaidano G; Luppi M; Marasca R
Exp Hematol; 2014 Feb; 42(2):126-36.e1. PubMed ID: 24212063
[TBL] [Abstract][Full Text] [Related]
14. HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy.
Nelde A; Kowalewski DJ; Backert L; Schuster H; Werner JO; Klein R; Kohlbacher O; Kanz L; Salih HR; Rammensee HG; Stevanović S; Walz JS
Oncoimmunology; 2018; 7(4):e1316438. PubMed ID: 29632711
[TBL] [Abstract][Full Text] [Related]
15. CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells.
Vaisitti T; Aydin S; Rossi D; Cottino F; Bergui L; D'Arena G; Bonello L; Horenstein AL; Brennan P; Pepper C; Gaidano G; Malavasi F; Deaglio S
Leukemia; 2010 May; 24(5):958-69. PubMed ID: 20220774
[TBL] [Abstract][Full Text] [Related]
16. A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment.
Ferretti E; Bertolotto M; Deaglio S; Tripodo C; Ribatti D; Audrito V; Blengio F; Matis S; Zupo S; Rossi D; Ottonello L; Gaidano G; Malavasi F; Pistoia V; Corcione A
Leukemia; 2011 Aug; 25(8):1268-77. PubMed ID: 21546901
[TBL] [Abstract][Full Text] [Related]
17. Lenalidomide in chronic lymphocytic leukemia: the present and future in the era of tyrosine kinase inhibitors.
Maffei R; Colaci E; Fiorcari S; Martinelli S; Potenza L; Luppi M; Marasca R
Crit Rev Oncol Hematol; 2016 Jan; 97():291-302. PubMed ID: 26454471
[TBL] [Abstract][Full Text] [Related]
18. Serine 727 phosphorylation of STAT3: an early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamine.
Miyakoshi M; Yamamoto M; Tanaka H; Ogawa K
Mol Carcinog; 2014 Jan; 53(1):67-76. PubMed ID: 22911886
[TBL] [Abstract][Full Text] [Related]
19. Lenalidomide in the treatment of chronic lymphocytic leukemia.
Gentile M; Recchia AG; Vigna E; Mazzone C; Lucia E; Gigliotti V; Bossio S; Madeo A; Morabito L; Servillo P; Franzese S; Caruso N; De Stefano L; Bisconte MG; Gentile C; Morabito F
Expert Opin Investig Drugs; 2011 Feb; 20(2):273-86. PubMed ID: 21214505
[TBL] [Abstract][Full Text] [Related]
20. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues.
Frank DA; Mahajan S; Ritz J
J Clin Invest; 1997 Dec; 100(12):3140-8. PubMed ID: 9399961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
